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Accepted 10 November 2014In 2003, theWorld Health Organization (WHO) deﬁnedminimal
deviation adenocarcinoma (MDA) as endocervical adenocarcinoma
mucinous, well differentiated, consisting of an endocervical glan-
dular hyperplasia of lobular architecture resembling glands but
with the characteristics of adenocarcinoma [1]. However, MDA has
been recently reclassiﬁed as a subcategory of gastric-type
mucinous carcinoma by WHO and is reserved only for extremely
well-differentiated cell types. [2]. MDA is a rare histological entity
of cervix adenocarcinoma. Cervical cytology provides an imperfect
diagnosis of glandular cells compared to squamous lesions,
although the 2001 Bethesda system still allows better management
of patients with abnormal glandular cells; the diagnosis is therefore
based on histological studies. In this report, we present the case of a
45-year-old woman with typical symptoms of MDA, in whom
cytological tests revealed atypical glandular cells; however, punch
biopsies and cervical conization failed to conﬁrm the diagnosis of
MDA despite reviewing literature pertaining to MDA.
A 45-year-old woman presented to our hospital with heavy
vaginal discharge for several months. Physical examination
revealed normal external genitalia and a large amount of mucoid
ﬂuid in the posterior vaginal fornix. Her cervix was grossly normal
in appearance except for the profuse mucoid discharge. She had
undergone bilateral adnexectomy in September 2010 due to the
presence of an ovarian cyst. Transvaginal sonography revealed a
normal cervix, hydrops in the endometrial cavity, and a small
ﬁbroid. The following Pap smear and cytological tests reported the
presence of atypical glandular cells of undetermined signiﬁcance
(AGUS), which was in favor of the diagnosis of adenocarcinoma of
the endocervix (Figures 1 and 2). However, despite undergoing four* Corresponding author. Department of Obstetrics and Gynecology, Kaohsiung
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1028-4559/Copyright © 2015, Taiwan Association of Obstetrics & Gynecology. Publishedendometrial curettings, two cervical biopsies, and one cervical
conization, she was diagnosed with only chronic cervical inﬂam-
mation and not with cervical disease or endometrial malignancy.
Subsequently, the patient underwent a total abdominal hysterec-
tomy. Pathologic examination of the specimen revealed MDA of the
cervix (Figures 3 and 4) with parametrial invasion and small sub-
serosal myomas. The tumor was staged as IIB MDA according to the
American Joint Committee on Cancer (AJCC) classiﬁcation. The
patient had an uneventful postoperative course and received
adjuvant therapy with concurrent chemoradiation therapy (CCRT).
She died 22 months after the surgery.
Minimal deviation adenocarcinoma (MDA), also known as ad-
enoma malignum (AM), is a well-known and extremely well-
differentiated type of mucinous endocervical adenocarcinoma. It
exhibits a gastric morphology and immunophenotype and is easily
misdiagnosed because of its benign-looking histological features.
MDA represents only 1e3% of all cervical adenocarcinomas and is
most likely unrelated to the human papillomavirus (HPV) [3,4].
The predominant clinical symptoms of MDA are profuse mucoid
vaginal discharge and irregular/contact vaginal bleeding [5,6]. Hirai
et al [7] reported profuse vaginal discharge in all cases, and Ki et al
[8] reported four cases, of which two had profuse watery or mucoid
vaginal discharge, one had irregular vaginal bleeding, and one had
both profuse vaginal discharge and irregular vaginal bleeding.
Pelvic examination may present grossly normal vaginal and cervi-
cal ﬁndings or cervical hypertrophy with multiple cystic lesions,
such as Nabothian cysts, in some cases [5,6].
Diagnosing MDA with the use of imaging techniques such as
magnetic resonance imaging (MRI) and ultrasonography is often
difﬁcult due to the benign appearance of this tumor; however,
these techniques play an important role in the evaluation of the
dissemination of MDA. Transvaginal sonography can detect the
presence of multilocular cystic masses in the uterine cervix and
may aid in the diagnosis of MDA [5,6]. Park et al [9] reported that
ultrasound imagingwith Doppler examination is more efﬁcient and
accurate in the evaluation of multilocular lesions of the uterine
cervix; they revealed that MDA had an increased intralesional
vascularity. In another study, MRI revealed multiple irregular cystic
lesions; the cysts were arranged in a ﬂoret-like manner with ag-
gregates of small cysts, resulting in a “cosmos (Cosmos bipinnatus)
pattern” [10]. MRI of MDA characteristically presents withby Elsevier Taiwan LLC. All rights reserved.
Figure 1. Uterine cervical smear displaying many atypical endocervical gland cells and
scant squamous epithelial component. Papanicolaou, 100.
Figure 3. Uterine cervix: numerous varied endocervical glands are seen scattered from
the subepithelium to the serosa. Hematoxylin and eosin, 40.
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markedly high signal intensity on T2WI. T2-weighted MRI shows
the MDA characteristics in detail and exhibits a reliable correlation
with histological ﬁndings [11e14].
A preoperative histological diagnosis of MDA is difﬁcult because
the pathological entity is composed of mucinous, very well-
differentiated glands deeply invading the cervical stroma, often
surrounded by a desmoplastic reaction. Cervical cancer screening is
done with a cytological evaluation performed using the Papanico-
laou (Pap) test. However, an accurate cytological diagnosis is difﬁ-
cult because the lesion is located deep in the endocervix and
presents with an endophytic growth pattern [15]. Ishii et al [15] and
Chang et al [6] reported similar cytologic features of MDA, which
are as follows: (1) the frequent appearance of large sheets of cells
with a honeycomb pattern and a palisading arrangement at the
periphery; (2) abnormal glandular cells with abundant cytoplasm
showing atypia and benign-appearing glandular cells; and (3)
slightly enlarged mucous cells with ovoid nuclei. Histologic ex-
amination reveals well-spaced, deeply invasive branching glands
lined with uniform columnar mucin-distended cells and infrequent
foci of less well-differentiated neoplastic cells [16]. Unlike other
adenocarcinomas, histologically, MDA rarely presents with mitoticFigure 2. Endocervical glandular epithelial cells show nuclear crowding and clearing
with gland-opening or acinar-like pattern. Prominent and displaced nucleoli are also
noted. Papanicolaou, 400.ﬁgures, pseudo-stratiﬁcation, or atypia; instead, in most cases, it
exhibits gastric differentiation with a high cytologic grade and as-
sociation with gastric metaplasia [4]. MDA is most likely unrelated
to HPV infection [17], which distinguishes it from common cervical
cancers, and therefore, it cannot be prevented by HPV vaccination
programs [4]. MDA was also associated with the PeutzeJeghers
syndrome with mutations in the STK11 gene [18]. Compared with
the usual type of cervical adenocarcinoma, MDA had a less favor-
able prognosis.
Immunohistochemical studies, which have been used for amore
accurate diagnosis, help differentiate MDA from a normal endo-
cervix and from other lesions, such as microglandular hyperplasia,
adenocarcinoma in situ, and well-differentiated endocervical
adenocarcinoma. Ishii et al [15] and Urusagi et al [19] reported that
mucinous MDA cells are positive for HIK1083. The HIK1083-labeled
latex agglutination test combined with other modalities may
facilitate the detection of MDA. Takatsu et al [10] presented a
combination of a diffusely solid pattern on MRI and atypical glan-
dular cells on smear and a positive gastric mucin test, which was
suggestive of MDA or gastric type adenocarcinoma. Mercer et al
[20] reported that MDA can be distinguished from well-
differentiated adenocarcinoma and other lesions with the use of
the carcinoembryonic antigen (CEA). Moreover, patients with AGUS
require further evaluation such as colposcopy in combination with
fractional curettage and/or cone biopsy owing to the possibility ofFigure 4. Uterine cervix: bland-looking endocervical glands penetrate the deep cer-
vical stroma. Hematoxylin and eosin, 200.
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rate, requiring follow-up or therapeutic intervention [21,22].
The treatment of MDA is similar to that of endocervical adeno-
carcinomas, and surgical intervention is the standard treatment for
both [8]. The type of surgery performed differs among surgeons due
to the difﬁculty in preoperative diagnosis. Lim et al [5] reported
patients who underwent Type I hysterectomywithout pelvic lymph
node dissection (PLND; 5 patients), Type I hysterectomy with PLND
(5 cases), and Type III radical hysterectomy (RH) with PLND (8
patients). Kudo et al [23] reported patients who underwent PLND
and external radiation (1 patients), radical hysterectomy and
external radiation (1 patient), radical hysterectomy, omentectomy,
and combination chemotherapy (1), and radical hysterectomy,
external radiation, and combination chemotherapy (1 patient). Ki
et al [8] reported patients who underwent simple hysterectomy
and bilateral adnexectomy (2 cases), Type I hysterectomy and pelvic
node sampling (1 case), and simple hysterectomy and PLND (1
case). In our case, the patient underwent Type 1 hysterectomy
without PLND combined with concurrent chemoradiation therapy.
The correlation between the type of surgery and survival rate is
unclear based on the results of the current study. This was possibly
due to the small sample size and the difﬁculties encountered in
reaching a preoperative diagnosis. Further investigation is there-
fore warranted.
MDAs are rare and are easily misdiagnosed. As standard
screening tests and diagnostic tools have not yet been established,
early diagnosis of MDA followed by an appropriate evaluation and
treatment has been a challenge for gynecologists. In conclusion, in
patients presenting with symptoms of heavy vaginal discharge, a
cystic lesion revealed on imaging, and atypical glandular cells on a
cytologic smear, MDA should be considered as a possible diagnosis.Conﬂicts of interest
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